Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity.
Marina Gabriela BirckCristiano Soares de MouraMarina A A MachadoJia Li LiuMichal AbrahamowiczLouise PiloteSasha BernatskyPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
Our evaluation using 3 different approaches, including adjustment for race/ethnicity, did not establish a clear difference between hydrochlorothiazide and ACE inhibitor in terms of skin cancer risk.